@article{c935a5012756428da1a94d73165f8d96,
title = "Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy",
abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the efficacy and safety of SCIg as induction and maintenance treatment in CIDP.",
author = "Bus, {Sander R. M.} and Luuk Wieske and Stephen Keddie and {van Schaik}, {Ivo N.} and Filip Eftimov",
note = "Funding Information: This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Neuromuscular Disease Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health. Cochrane Neuromuscular is also supported by the MRC Centre for Neuromuscular Disease. Funding Information: SK: Dr Keddie is employed by Barts and the Royal London NHS Trust and University College London Hospitals NHS Trust bank for clinical neurology work. Dr Keddie's research is funded by a clinical training research fellowship awarded by the Association of British Neurologists and Guarantors of Brain. Dr Keddie is a neurology specialist registrar and sees patients with chronic inflammatory demyelinating polyradiculoneuropathy on subcutaneous immunoglobulin. Publisher Copyright: Copyright {\textcopyright} 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",
year = "2021",
month = oct,
day = "9",
doi = "https://doi.org/10.1002/14651858.CD014542",
language = "English",
volume = "2021",
journal = "Cochrane Database of Systematic Reviews",
issn = "1465-1858",
publisher = "Wiley",
number = "10",
}